534 related articles for article (PubMed ID: 17295905)
1. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.
Yin H; Yeh LC; Hinck AP; Lee JC
J Mol Biol; 2008 Apr; 378(1):191-203. PubMed ID: 18342887
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
Nickel J; Dreyer MK; Kirsch T; Sebald W
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
[TBL] [Abstract][Full Text] [Related]
5. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding.
Mace PD; Cutfield JF; Cutfield SM
Biochem Biophys Res Commun; 2006 Dec; 351(4):831-8. PubMed ID: 17094948
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
Sebald W; Nickel J; Zhang JL; Mueller TD
Biol Chem; 2004 Aug; 385(8):697-710. PubMed ID: 15449706
[TBL] [Abstract][Full Text] [Related]
7. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
8. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
9. A single residue of GDF-5 defines binding specificity to BMP receptor IB.
Nickel J; Kotzsch A; Sebald W; Mueller TD
J Mol Biol; 2005 Jun; 349(5):933-47. PubMed ID: 15890363
[TBL] [Abstract][Full Text] [Related]
10. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.
Saremba S; Nickel J; Seher A; Kotzsch A; Sebald W; Mueller TD
FEBS J; 2008 Jan; 275(1):172-83. PubMed ID: 18070108
[TBL] [Abstract][Full Text] [Related]
11. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.
Kirsch T; Nickel J; Sebald W
EMBO J; 2000 Jul; 19(13):3314-24. PubMed ID: 10880444
[TBL] [Abstract][Full Text] [Related]
12. [Bone morphogenetic protein (BMP) receptors and signal transduction].
Yamashita H; Miyazono K
Nihon Rinsho; 1999 Jan; 57(1):220-6. PubMed ID: 10036966
[TBL] [Abstract][Full Text] [Related]
13. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
Ahmed S; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
[TBL] [Abstract][Full Text] [Related]
15. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP
Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111
[TBL] [Abstract][Full Text] [Related]
16. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.
Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW
J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349
[TBL] [Abstract][Full Text] [Related]
17. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
[TBL] [Abstract][Full Text] [Related]
18. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors.
Allendorph GP; Isaacs MJ; Kawakami Y; Izpisua Belmonte JC; Choe S
Biochemistry; 2007 Oct; 46(43):12238-47. PubMed ID: 17924656
[TBL] [Abstract][Full Text] [Related]
19. Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation.
Liu H; Zhang R; Chen D; Oyajobi BO; Zhao M
J Cell Physiol; 2012 Mar; 227(3):952-63. PubMed ID: 21503889
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
Yeh LC; Betchel KP; Lee JC
J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
